Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 27, 2026 08:36 ET | Source: Grabar Law Office

Notice to Long-Term Shareholders of Commvault Systems, Inc. (NASDAQ: CVLT); MongoDB, Inc. (NASDAQ: MDB); New Era Energy & Digital, Inc. (NASDAQ: NUAI); and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN): Grabar Law Office is Investigating Claims on Your Behalf

Commvault Systems (NASDAQ: CVLT); MongoDB (NASDAQ: MDB); New Era Energy & Digital (NASDAQ: NUAI); and Regeneron Pharmaceuticals (NASDAQ: REGN) Shareholders
May 26, 2026 08:17 ET | Source: Grabar Law Office

Important Notice to Long-Term Shareholders of Molina Healthcare, Inc. (NYSE: MOH); MongoDB, Inc. (NASDAQ: MDB); New Era Energy & Digital, Inc. (NASDAQ: NUAI); and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Grabar Law Office is Investigating Claims on Your Behalf

Notice: Molina Healthcare(NYSE: MOH); MongoDB (NASDAQ: MDB); New Era Energy & Digital (NASDAQ: NUAI); and Regeneron Pharmaceuticals (NASDAQ: REGN)
February 18, 2025 19:53 ET | Source: Robbins LLP

REGN STOCK NEWS: Robbins LLP Reminds Regeneron Pharmaceuticals, Inc. Investors of the Pending Lead Plaintiff Deadline – March 4, 2025

Robbins LLP is Investigating Allegations that Regeneron Pharmaceuticals, Inc. (REGN) Misled Investors Regarding its Business Prospects
January 17, 2025 17:20 ET | Source: Robbins LLP

Robbins LLP Urges REGN Stockholders with Large Losses to Contact the Firm for Information About the Class Action Against Regeneron Pharmaceuticals, Inc

Robbins LLP is Investigating Allegations that Regeneron Pharmaceuticals, Inc. (REGN) Misled Investors Regarding its Business Prospects
January 13, 2025 21:48 ET | Source: Robbins LLP

REGN Shareholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors Class Action Against Regeneron Pharmaceuticals, Inc.

Robbins LLP is Investigating Allegations that Regeneron Pharmaceuticals, Inc. (REGN) Misled Investors Regarding its Business Prospects
January 08, 2025 18:38 ET | Source: Robbins LLP

Stockholder Notice: Robbins LLP Informs Stockholders of the Regeneron Pharmaceuticals, Inc. Class Action Lawsuit

Robbins LLP is Investigating Allegations that Regeneron Pharmaceuticals, Inc. (REGN) Misled Investors Regarding its Business Prospects